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Peri-implantitis is characterized by inflammation and crestal bone loss in the tissues surrounding implants. Contamination by
deleterious bacteria in the peri-implant microenvironment is believed to be a major factor in the etiology of peri-implantitis. Prior
to any therapeutic regenerative treatment, adequate decontamination of the peri-implant microenvironment must occur. Herein
we present a novel approach to the treatment of peri-implantitis that incorporates the use of a topical desiccant (HYBENX), along
with air powder abrasives as a means of decontamination, followed by the application of biphasic calcium sulfate combined with
inorganic bovine bone material to augment the intrabony defect. We highlight the case of a 62-year-old man presenting peri-
implantitis at two neighboring implants in positions 12 and 13, who underwent access flap surgery, followed by our procedure.
After an uneventful 2-year healing period, both implants showed an absence of bleeding on probing, near complete regeneration
of the missing bone, probing pocket depth reduction, and clinical attachment gain. While we observed a slight mucosal recession,
there was no reduction in keratinized tissue. Based on the results described within, we conclude that the use of HYBENX and air
powder abrasives, followed by bone defect grafting, represents a viable option in the treatment of peri-implantitis.
1. Introduction
Peri-implantitis is a condition that affects the mucosa and
bone surrounding dental implants and is characterized by
crestal bone loss [1, 2]. Depending on the qualification
criteria, the incidence of peri-implantitis ranges from 18.8%
to 51.9% [3–5]. It is generally accepted that the colonization
of deleterious bacteria in the peri-implantmicroenvironment
plays a major role in the etiology of peri-implantitis [1, 6–
8]. Polymicrobial communities that colonize different micro-
habitats within the mouth are referred to as a biofilm [9, 10].
Similar to periodontitis, treatment modalities aimed at cor-
recting peri-implantitis include the reduction or elimination
of deleterious bacteria within the biofilms that coat the oral
surfaces [11, 12].
Removal of oral biofilms, or the decontamination of
the peri-implant microenvironment in patients suffering
from peri-implantitis, can be achieved through both surgical
and nonsurgical means [11, 12]. Proposed treatments for
the decontamination of microenvironments during peri-
implantitis include antibiotic and antiseptic treatment (both
local and systemic), mechanical debridement, and laser
treatment [13]. Surgical techniques are also used in the
treatment of peri-implantitis, with the rationale that surgery
grants increased access to the spaces inhabited by deleterious
bacteria [13, 14]. However, strong evidence supporting any
particular therapy in the treatment of peri-implantitis has
yet to be established [13, 14]. In light of this, we attempted
to treat a case of peri-implantitis using a topical desiccant
(HYBENX Oral Tissue Decontaminant, EPIEN Medical,
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Figure 1: The baseline periapical radiograph indicated a deep
interproximal peri-implant bone lesion.
Figure 2: Initial probing revealed a deep peri-implant pocket
between 2 short, single-crown locking taper implants, in positions
12 and 13.
Inc.) as an adjunct to air powder abrasion (Airflow, EMS),
followed by the application of an inorganic bone composite
comprised of a mixture of bovine bone material (Bio-Oss,
Geistlich Biomaterials) mixed with biphasic calcium sulfate
(BondBone,MIS Implants Technologies Ltd.). HYBENX is an
extremely hygroscopic solution that theoretically functions
by denaturing the attachment proteins used by bacteria to
adhere to the implant surface. This allows the more efficient
subsequent removal of biofilm microbes. To our knowledge,
no study using a topical desiccant as an adjunct to air powder
abrasives has been published to date.
Here we report the treatment protocol and two-year
follow-up of a 62-year-old patient who was treated using
our novel surgical protocol for peri-implantitis. Based on the
successful outcome our patient exhibited, we conclude that
the use of a HYBENX as an adjunct to air powder abrasion,
followed by composite bone grafting using inorganic bovine
bone mixed with biphasic calcium sulfate, represents a
possible future treatment for peri-implantitis that warrants
further consideration and study.
2. Case Report
A 62-year-old man reported discomfort and bleeding that
occurred while brushing around his two single crown
Figure 3: After elevation of the vestibular and palatal full thickness
flaps, a crater-like defect characterized by interproximal bone loss
was observed around the implants.
Figure 4: After elevation of the vestibular and palatal full thickness
flaps, a crater-like defect characterized by interproximal bone loss
was observed around the implants.
implants (upper left premolars: tooth numbers 12 and 13).
Periapical radiographs revealed a large apical lesion adjacent
to the neighboring molar and a bone loss pattern suggestive
of peri-implantitis around the indicated implants (Figure 1).
Probing pocket depths ranged from 7 to 9mm (Figure 2). Ini-
tial treatment included the nonsurgical mechanical debride-
ment of implants using ultrasonic devices and reinstruction
in oral hygiene techniques. This initial treatment unfortu-
nately resulted in insignificant reductions of pocket depths
and inflammation.
Following the initial nonsurgical treatment, the option
of removing the prosthesis to allow submerged healing was
presented to and declined by the patient. After discussing
the inherent risks involved, the patient gave written consent
and agreed to proceed with open debridement and decon-
tamination, followed by guided bone regeneration using bone
composite [15].
In order to minimize clinical signs of inflammation,
a single course of low abrasive air powder (Airflow) was
implemented two weeks before surgery.
The surgical procedure is described as follows: briefly,
after local infiltration of a 2% lidocaine solution with
Case Reports in Dentistry 3
Figure 5: HYBENXwas administered on the implant surface for 60
seconds and then thoroughly rinsed away with saline.
Figure 6: Debridement of the implant surfaces using air powder
abrasion for 60 seconds.
1mcg/mL epinephrine, sulcular incisions were made on the
buccal and lingual/palatal side in an effort to preserve soft
tissue. Full thickness flapswere then elevatedwith a periosteal
release to allow for adequate flap mobilization and coronal
advancement at the time of closure.
Interproximal tissue was then removed and—after a
thorough degranulation of the osseous defects—surgical
exposure of the coronal portion of the implants was pro-
vided. Smoothening of buccally and supracrestally exposed
implant parts was performed with the use of rotating burs
(i.e., implantoplasty) (Figures 3 and 4) [16, 17]. The surface
decontamination procedure consisted of a 3-step protocol
that was repeated twice:
(1) Application of HYBENX to the defect and implant
surface, with 60-second incubation period (Figure 5).
(2) Abundant irrigation of the defect with saline solution.
(3) Administration of sodium bicarbonate-based abra-
sive air powder treatment (Airflow) to all contami-
nated and exposed parts of the implant surface for 60
seconds (Figure 6).
After the second round of surface decontamination had con-
cluded, bone defects were filled with a composite graft that
Figure 7: Following decontamination of the implant surface, a
mixture of biphasic calcium sulfate and inorganic bovine bone
were applied to defect at the buccal and palatal location (without
a membrane).
Figure 8: Following decontamination of the implant surface, a
mixture of biphasic calcium sulfate and inorganic bovine bone
were applied to defect at the buccal and palatal location (without
a membrane).
was created by mixing the inorganic portion of bovine bone
(Bio-Oss) with a synthetic biphasic calcium sulfate material
(BondBone). Bio-Oss (0.5mg) and BondBone (0.5 g) were
combined with Rifampicin (1 vial, Sanofi-Aventis) to produce
the composite. Because the composite bone graft possesses
the ability to harden in the presence of blood and saliva,
we decided to forgo the use of graft retaining membranes
(Figures 7 and 8). The flap was then mobilized and advanced
in order to obtain a primary tension-free closure (Figures 9
and 10). Following the procedure, postoperative radiographs
were taken to evaluate the level of the defect filling (Figure 11).
Postoperative care included a 0.12% chlorhexidine +
0.05% cetylpyridinium chloride (CPC) rinse (GUM Paroex,
Sunstar Suisse S.A.) twice daily for 2 weeks, 1 g of amoxicillin
every 12 hours for 7 days, and 800mg of ibuprofen as needed
for pain. Following the procedure the patient was instructed
to abstain from brushing for two weeks and flossing for one
month.
The patient was evaluated one week following the pro-
cedure. At two weeks, the patient was reevaluated and the
sutures were removed. Four weeks after procedure the patient
underwent surgical area debridement and home oral hygiene
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Figure 9: The mucoperiosteal flap was repositioned to ensure
transmucosal healing and proper wound closure.
Figure 10: The mucoperiosteal flap was repositioned to ensure
transmucosal healing and proper wound closure.
techniques were reinforced. The patient was placed on an 8–
12 week recall schedule until the completion of treatment (2
years), during which time periapical radiographs were taken
every 6 months.
3. Results
Measurements derived from clinical observations are sum-
marized in Table 1 and represent the mean of four sampling
sites surrounding each implant (i.e. buccal, lingual/palatal,
mesial, and distal) both immediately before surgery (base-
line) and at the 2-year time point.
Bone level changes and percentage of bone fill were
measured using scanning intraoral radiographs with parallel
technique, using Rinn centering devices (Rinn XCP Poste-
rior Aiming Ring-Yellow, Dentsply, Elgin, IL). First bone-
to-implant contact changes were assessed as described by
Urdaneta et al. (2010) [18]. Implant measurements taken
from radiographs were calibrated to actual implant lengths by
using ImageJ to calculate the pixel/mm ratio of radiographs
taken at baseline and after 2 years.
After an uneventful healing period of one year, clinical
evaluations revealed healthy peri-implant hard and soft
tissues (Figures 12 and 13). Two years after procedure, a
Figure 11: Postoperative radiograph indicating complete filling of
the peri-implant defect.
Figure 12: One-year after procedure, an absence of bleeding and
reduced probing depth was observed.
complete absence of bleeding upon probing along with
physiological probing was observed (Figures 14 and 15). A
slight recession of the soft tissues without a change in the
height of keratinized tissue was also observed (Table 1).
Radiograph measurements reflecting bone level changes
and the percentage of bone fill are summarized in Table 2.
Radiographs revealed that the initial bony defect had been
almost completely regenerated (Figure 16), and increases in
radiographic first bone-to-implant contact were observed at
both the mesial (2.9mm and 6.7mm at numbers 12 and 13,
resp.) and distal regions (8.0mm and 5.6mm at numbers 12
and 13, resp.).
4. Discussion
Peri-implantitis is responsible for the majority of implant
failures [3, 14, 17]. Defined as an irreversible condition with a
relatively high—and possibly underreported—incidence rate,
the prevention and treatment of peri-implantitis should be of
the utmost concern to every clinician [3–5, 13].
Many factors come into play when choosing an appro-
priate treatment for peri-implantitis. Overall patient health,
location of the defect, and progression of the disease are
all factors that should be considered. When probing depths
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Table 1: Postsurgical clinical observations taken at baseline and 2 years. Baseline values were obtained immediately before surgery. Results
are expressed as Mean ± SD and are the average values of the four areas investigated. BOP = bleeding on probing, PD = probing depth, MR
= mucosal recession, CAL = clinical attachment level, and KM = keratinized mucosa width.
Implant site
(tooth number)
PPD (mm) BOP (%) MR KM CAL
Baseline 2 years Baseline 2 years Baseline 2 years Baseline 2 years Baseline 2 years
12 7.0 ± 1.8 2.7 ± 0.5 100 0 1.2 ± 0.7 1.0 ± 0.9 2.3 ± 0.6 2.4 ± 0.6 8.2 ± 2.3 3.7 ± 0.8
13 8.3 ± 1.0 2.8 ± 0.4 100 0 0.8 ± 0.7 1.4 ± 0.5 1.0 ± 1.0 1.0 ± 1.0 9.2 ± 1.2 4.1 ± 0.8
Table 2: Radiographic observations observed at baseline after 2 years and expressed as variations after 2 years. Baseline values were obtained
immediately before surgery.Δ= changes of values comparedwith baseline after 2-year follow-up period. r-BF = the percentage of radiographic
bone fill of the defect at 2 years.
Implant site
(tooth number)
First bone-to-implant contact (FBIC)
Mesial (mm) Distal (mm) r-BF (%)
Baseline 2 years Δ Baseline 2 years Δ
12 −3.0mm −0.1mm +2.9mm −8.1mm −0.1mm +8.0mm 93.0%
13 −6.9mm −0.2mm +6.7mm −5.8mm −0.2mm +5.6mm 91.6%
Figure 13: One-year postoperative radiographs depicting radiopac-
ity at the location of the defect.
exceed 5mm, bleeding on probing occurs, and conventional
nonsurgical options have been exhausted; then surgical
intervention involving open debridement with resective or
regenerative therapy should be performed [19–21].
We chose to pursue a novel course of treatment that
utilized a topical desiccant and air powder abrasion to decon-
taminate the afflicted site, followed by grafting a mixture of
biphasic calcium sulfate and inorganic bovine bone. The use
of air powder abrasion during open flap surgical procedures
has been shown to be an efficient decontamination measure
both in vitro and in vivo [22–28]. And surfaces treated
with air powder abrasives do not significantly affect the
viability of human gingival fibroblasts and osteosarcoma
cells, in vitro [29, 30]. Despite the efficacious nature of air
powder abrasion as highlighted in the relevant literature,
defect and implant morphology can potentially diminish
its effectiveness (especially in cases of narrow defects and
around implant threads) [22–28, 31]. In addition, the use of
adjunctive antibiotics or antiseptics to air powder abrasion
has yielded favorable outcomes [32]. Bearing this inmind, we
Figure 14: Two-year postoperative clinical examination revealed
health hard and soft tissues with no bleeding and reduced probing
depth (buccal and lingual/palatal probing shown).
chose to use the desiccating agent HYBENX as an adjunct to
air powder abrasion.
HYBENX—an extremely hygroscopic solution com-
prised of hydroxymethoxybenzenesulfonic and hydroxyben-
zenesulfonic acid isomers, sulfuric acid, and water—has been
used in the treatment of recurrent aphthous stomatitis [33].
The use of HYBENX was pursued in an attempt to boost
the efficacy of our decontamination procedure, by denaturing
adherence proteins used by bacteria in narrow defects and on
implant threads, allowing them to be more easily rinsed away
[31].
Subsequent to decontamination, we grafted a combina-
tion of inorganic bovine bone with biphasic calcium sulfate,
in the absence of a membrane. Membranes (in the context of
implant surgeries) serve as scaffolds to guide bone growth as
well as barriers to soft tissue invasion [34, 35]. Owing to the
fact that the novel composite we used possesses the ability
to harden in the presence of saliva and blood (and in light
of a report indicating no significant difference between bone
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Figure 15: Two-year postoperative clinical examination revealed
health hard and soft tissues with no bleeding and reduced probing
depth (buccal and lingual/palatal probing shown).
Figure 16: Two-year postoperative radiographs depicting radiopac-
ity at the location of the defect, showing a near complete regenera-
tion of the missing bone.
fill levels when comparing resorbable membranes to bone
substitute alone), we decided to forgo the use of membranes
[36].
5. Conclusion
The absence of morbidity and remarkably uneventful healing
period our patient exhibited suggest that the technique
described here may represent a successful procedure in
the treatment of peri-implantitis. Clinical and radiographic
evidence presented here corroborate the efficacy of this
procedure. Based on the outcomes of this report, future
work using this novel decontamination and bone grafting
procedure should be considered.
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